Literature DB >> 512041

Platelet function in hairy-cell leukaemia.

M Zuzel, J C Cawley, R C Paton, G F Burns, G P McNicol.   

Abstract

A quantitative study of various aspects of platelet function was carried out in eight patients with typical hairy-cell leukaemia (HCL). In at least two patients platelet aggregation was convincingly reduced to more than one aggregating agent (ADP, adrenaline, collagen, thrombin, and ristocetin). Granular storage capacity for {(14)C} 5-HT was reduced in five of the six patients tested. The two patients with definitely abnormal aggregation had the greatest reduction in granular storage pool and the longest bleeding times of those tested but, like the other patients, they did not have a clinical haemostatic defect. It was concluded that a granular storage pool defect (SPD) was at least partly responsible for aggregation abnormalities in HCL since the platelet release reaction in response to thrombin appeared to be normal. All our patients ran a chronic course uncomplicated by any of the factors known to predispose to a platelet SPD acquired in the circulation. Although in the one patient tested before and after splenectomy there was some improvement in platelet aggregation after operation, there was no clear general relationship between defective platelet function and either previous splenectomy or platelet count. Since a direct involvement of the megakaryocytic series in the underlying cell proliferation of HCL seems unlikely, it is concluded that the platelet defect can most reasonably be attributed to the production of abnormal platelets as a result of marrow fibrosis and/or infiltration by hairy cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512041      PMCID: PMC1145815          DOI: 10.1136/jcp.32.8.814

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  29 in total

1.  PLATELET SEQUESTRATION IN MAN. I. METHODS.

Authors:  R H ASTER; J H JANDL
Journal:  J Clin Invest       Date:  1964-05       Impact factor: 14.808

2.  Leukemic reticuloendotheliosis.

Authors:  B A BOURONCLE; B K WISEMAN; C A DOAN
Journal:  Blood       Date:  1958-07       Impact factor: 22.113

3.  Morphology and enumeration of human blood platelets.

Authors:  G BRECHER; E P CRONKITE
Journal:  J Appl Physiol       Date:  1950-12       Impact factor: 3.531

Review 4.  Hairy-cell leukaemia and prolymphocytic leukaemia.

Authors:  D Catovsky
Journal:  Clin Haematol       Date:  1977-02

5.  Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics.

Authors:  H M Golomb; J Vardiman; D L Sweet; D Simon; D Variakojis
Journal:  Br J Haematol       Date:  1978-02       Impact factor: 6.998

6.  Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia.

Authors:  J M Gerrard; S F Stoddard; R S Shapiro; P F Coccia; N K Ramsay; M E Nesbit; G H Rao; W Krivit; J G White
Journal:  Br J Haematol       Date:  1978-12       Impact factor: 6.998

Review 7.  Hairy cell leukemia: an unusual lymphoproliferative disease: a study of 24 patients.

Authors:  H M Golomb
Journal:  Cancer       Date:  1978-08       Impact factor: 6.860

8.  Hairy cell leukaemia. Clinical features and effect of splenectomy.

Authors:  J Jansen; J Hermans; J Remme; G J den Ottolander; P L Cardozo
Journal:  Scand J Haematol       Date:  1978-07

9.  Leukemic reticuloendotheliosis. Loss of platelet defect after splenectomy.

Authors:  A S Feiner; A M Meyers; G E Moore
Journal:  JAMA       Date:  1978-07-21       Impact factor: 56.272

10.  Platelet 5-hydroxytryptamine (HT) in disorders of the blood.

Authors:  R M HARDISTY; R S STACEY
Journal:  Br J Haematol       Date:  1957-07       Impact factor: 6.998

View more
  1 in total

Review 1.  Hairy cell leukaemia and venous thromboembolism: a case report and review of the literature.

Authors:  Natale Vazzana; Raffaele Spadano; Simona Sestili; Valentina Toto; Simona Falorio; Virginia Catinella; Francesco Angrilli; Alfredo Dragani
Journal:  Blood Transfus       Date:  2014-04       Impact factor: 3.443

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.